- Home
- PTLO vs VSTM Comparison
PTLO vs VSTM Comparison
Compare PTLO & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTLO
- VSTM
- Stock Information
- Founded
- PTLO 1963
- VSTM 2010
- Country
- PTLO United States
- VSTM United States
- Employees
- PTLO N/A
- VSTM N/A
- Industry
- PTLO Restaurants
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- PTLO Consumer Discretionary
- VSTM Health Care
- Exchange
- PTLO Nasdaq
- VSTM Nasdaq
- Market Cap
- PTLO 458.8M
- VSTM 493.6M
- IPO Year
- PTLO 2021
- VSTM 2012
- Fundamental
- Price
- PTLO $5.72
- VSTM $8.07
- Analyst Decision
- PTLO Buy
- VSTM Strong Buy
- Analyst Count
- PTLO 9
- VSTM 9
- Target Price
- PTLO $10.50
- VSTM $13.38
- AVG Volume (30 Days)
- PTLO 3.2M
- VSTM 2.1M
- Earning Date
- PTLO 11-04-2025
- VSTM 11-04-2025
- Dividend Yield
- PTLO N/A
- VSTM N/A
- EPS Growth
- PTLO 17.90
- VSTM N/A
- EPS
- PTLO 0.46
- VSTM N/A
- Revenue
- PTLO $727,754,000.00
- VSTM $2,137,000.00
- Revenue This Year
- PTLO $6.43
- VSTM $79.32
- Revenue Next Year
- PTLO $9.66
- VSTM $413.52
- P/E Ratio
- PTLO $12.51
- VSTM N/A
- Revenue Growth
- PTLO 3.62
- VSTM N/A
- 52 Week Low
- PTLO $5.58
- VSTM $3.11
- 52 Week High
- PTLO $15.78
- VSTM $11.25
- Technical
- Relative Strength Index (RSI)
- PTLO 32.65
- VSTM 42.55
- Support Level
- PTLO $5.58
- VSTM $7.60
- Resistance Level
- PTLO $5.99
- VSTM $9.90
- Average True Range (ATR)
- PTLO 0.23
- VSTM 0.65
- MACD
- PTLO 0.01
- VSTM -0.16
- Stochastic Oscillator
- PTLO 12.39
- VSTM 36.99
About PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.